Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress
2013
Krüppel-like factor 8 emerges as an important regulator of cancer.
2012
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
2012
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
2013
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
2012
Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma
2012
Identification of Stably Expressed lncRNAs as Valid Endogenous Controls for Profiling of Human Glioma
2015
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Role of Imaging in the Era of Precision Medicine
2017
The future of high-grade glioma: Where we are and where are we going
2015
Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence
2017
Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease
2008
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma
2017
The Thrombospondins
2011 Standout
TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine
2013
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
2013
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Advances in the molecular genetics of gliomas — implications for classification and therapy
2016
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
2015
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis
2013
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study
2018
Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas
2013
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
What do we know about IDH1/2 mutations so far, and how do we use it?
2013
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
2012
The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms
2013
Identification of copy number variants in whole-genome data using Reference Coverage Profiles
2015 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Detection of 2-Hydroxyglutarate in IDH -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
2012
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
2012
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Fundamentals of cancer metabolism
2016 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion
2011
RNAi Reduces Expression and Intracellular Retention of Mutant Cartilage Oligomeric Matrix Protein
2010
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression
2019 StandoutNobel
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
2014
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Protoporphyrin IX Fluorescence and Photobleaching During Interstitial Photodynamic Therapy of Malignant Gliomas for Early Treatment Prognosis
2013
IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
2012
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of Sabina Eigenbrod being referenced
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients
2014
Sphingosine Kinase and Sphingosine-1-Phosphate Regulate Migration, Endocytosis and Apoptosis of Dendritic Cells
2006
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status
2012
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
2011
Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health Organization Grade II Gliomas
2009
IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival
2011
Low values of 5‐hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors
2012
Krüppel-Like Factor 8 (KLF8) Is Expressed in Gliomas of Different WHO Grades and Is Essential for Tumor Cell Proliferation
2012
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
2011
Optical needle endoscope for safe and precise stereotactically guided biopsy sampling in neurosurgery
2012
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide
2010
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
2006
O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
2011
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
2012
Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM
2015
Dynamic 18F‐FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses
2014
[18F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma
2013